Passive therapy with humanized anti-staphylococcal enterotoxin B antibodies attenuates systemic inflammatory response and protects from lethal pneumonia caused by staphylococcal enterotoxin B-producing Staphylococcus aureus

Drugs such as linezolid that inhibit bacterial protein synthesis may be beneficial in treating infections caused by toxigenic Staphylococcus aureus. As protein synthesis inhibitors have no effect on preformed toxins, neutralization of pathogenic exotoxins with anti-toxin antibodies may be beneficial...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
الحاوية / القاعدة:Virulence
المؤلفون الرئيسيون: Karau, Melissa J., Tilahun, Mulualem E., Krogman, Ashton, Osborne, Barbara A., Goldsby, Richard A., David, Chella S., Mandrekar, Jayawant N., Patel, Robin, Rajagopalan, Govindarajan
التنسيق: Artigo
اللغة:Inglês
منشور في: Taylor & Francis 2016
الموضوعات:
Research Paper
الوصول للمادة أونلاين:https://ncbi.nlm.nih.gov/pmc/articles/PMC5711449/
https://ncbi.nlm.nih.gov/pubmed/27925510
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21505594.2016.1267894
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة